Double-blind, Randomized, Placebo-controlled Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0974 in Healthy Male Subjects

Trial Profile

Double-blind, Randomized, Placebo-controlled Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0974 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Feb 2016

At a glance

  • Drugs GLPG 0974 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 08 Feb 2016 Results of this and other trial (see profile 213949) published in the British Journal of Clinical Pharmacology
    • 16 Oct 2013 Results will be presented at the United European Gastroenterology Week, according to a media release.
    • 27 Mar 2013 Results have been published in a Galapagos NV media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top